- Giant Biogene Holding, a China skincare products supplier that debuted on the Hong Kong Stock Exchange on Nov. 4, raised $10 million by selling 3.39 million over-allotment shares for HK$24.30, or $3.11 apiece.
- Giant raised HK$495.8 million before going public.
- Giant lost 7% and traded at HK$25 at lunchtime today, valuing Fan Daidi’s holding at $2 billion.
China’s largest skincare company, Biogene, raises $10 million in its IPO over-allotment.
Published on
